STOCK BASED COMPENSATION |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK BASED COMPENSATION |
We grant equity compensation awards to directors, employees, and contractors under the 2021 Omnibus Equity Compensation Plan. We have granted restricted stock units (“RSUs”) and stock options with service-based vesting conditions with vesting typically occurring over a -year period.
Restricted Stock Units
On December 20, 2024, our Board of Directors authorized awarding vesting over . On March 3, 2025, we granted RSUs to officers and employees. During the quarter ended June 30, 2025, we awarded RSUs to new employees vesting over beginning on March 1, 2026 and ending on March 1, 2028. The average grant date fair value of RSUs granted during the nine months ended June 30, 2025, was $. The Company recognizes compensation cost for unvested share-based awards on a straight-line basis over the requisite service period.
Our total stock-based compensation expense for the nine months ended June 30, 2025, was $ thousand for the amortization of outstanding equity compensation grants. Stock-based compensation of $ thousand is included in general and administrative expense, $ thousand in selling and marketing expense, and $ thousand in research and development expense.
The unamortized stock compensation expense at June 30, 2025, is $ thousand, and the remaining weighted average term to vesting is years.
Stock Options
The following table summarizes the activity of our stock options granted under our Equity Incentive Plan during the nine months ended June 30, 2025:
On December 20, 2024, our Board of Directors authorized the termination of stock options previously awarded to independent directors.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||